about
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.Addressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksMarburg Virus Reverse Genetics SystemsEbolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop.Fusion of Enveloped Viruses in Endosomes.Ebola: translational science considerationsThe Roles of Histidines and Charged Residues as Potential Triggers of a Conformational Change in the Fusion Loop of Ebola Virus Glycoprotein.A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining stepEndocytosis of viruses and bacteria.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccineChemical and Structural Aspects of Ebola Virus Entry Inhibitors.Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry InhibitorsComparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976.TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope.Lentiviral vector gene transfer to porcine airways.Retrovirus entry by endocytosis and cathepsin proteases.IFITMs restrict the replication of multiple pathogenic virusesEbola virus entry into host cells: identifying therapeutic strategies.Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.Entry of Ebola Virus is an Asynchronous Process.Therapeutics for postexposure treatment of Ebola virus infection.Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity.Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol.Mechanisms of Filovirus Entry.Virology. Delineating Ebola entry.Axl can serve as entry factor for Lassa virus depending on the functional glycosylation of dystroglycan.Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop
P2860
Q24568225-634FA7F8-2F4B-4BD0-A9AC-CB033A5DD29EQ26801423-3187590B-2A3C-4AEC-A0DF-8A4F59C44E37Q27015752-C83623A4-2309-4C13-A45A-119F2B13E1AAQ27682816-951B3627-78A5-4787-8BB9-C85D3549B58DQ28073406-E16DFF06-852C-4EBF-A75F-3F1B02C90337Q28082994-055CD6C6-AB59-4C33-81CB-D7C4901B45C8Q30277079-CFCE93FA-67F3-49B2-825B-982437086949Q30279239-27DDC968-6993-4DD9-8ED0-D59AFD7ABFDEQ30301030-7CC4EF37-FB9A-48B1-8485-BDE5970E2633Q33938568-22842BDA-A047-44B7-BECF-D3500C580517Q34463780-85365FA7-748F-49A4-A03F-C668822954CEQ34478514-F00FE016-DE9D-4EB1-8749-35C82C53BE84Q35184639-2A985F51-EF11-4506-A39E-23D4131E73F2Q35589926-CA064986-B752-44C2-BE69-F7BE3C3F7D82Q36012840-2C5C2D05-6CDF-4FC3-856D-022F14EB332BQ36043193-77248CEF-9E7D-4398-AE95-54BA1F97403AQ36220496-7A3C00AF-2EE5-4602-83DB-447F78A79558Q36438300-B65CE7BA-ACC0-40F2-809A-217046C9390AQ36469011-F2677B79-D85C-4BFC-A05E-4A7A5CA2F05EQ38146443-FF04ABF9-5027-49AF-A4CC-7BB4206AF80CQ38618148-78EF4012-3D85-4618-924F-96CF60E06E25Q38860071-20A25F70-5544-492B-9428-70CC6DE11F2AQ38879034-A7B16661-1117-4B5D-A13E-07E85CA423C3Q38980947-4F06438E-B3DF-40B6-8668-08FDF4FD8DB0Q39175134-BCF3FA4C-B0BF-4279-B8E2-A95048BA4EF1Q40040589-F5155B6C-B452-4F01-8FC0-D732792D9F8EQ40148056-174693FD-CFB4-47AC-890E-F69D87571137Q40164611-C0F8E1EE-A0CA-42BF-B9BD-EBB982F97692Q40167735-E45DC5F8-7D8B-48C7-903B-74382F2FB220Q47296347-ACA0E078-8E71-42BC-8A53-79DEE3AAAA3BQ58764092-1622E494-FCFC-4C9A-ADA6-E6CA722C209C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Filovirus entry: a novelty in the viral fusion world.
@en
Filovirus entry: a novelty in the viral fusion world.
@nl
type
label
Filovirus entry: a novelty in the viral fusion world.
@en
Filovirus entry: a novelty in the viral fusion world.
@nl
prefLabel
Filovirus entry: a novelty in the viral fusion world.
@en
Filovirus entry: a novelty in the viral fusion world.
@nl
P2093
P2860
P356
P1433
P1476
Filovirus entry: a novelty in the viral fusion world.
@en
P2093
Catherine L Hunt
Nicholas J Lennemann
Wendy Maury
P2860
P304
P356
10.3390/V4020258
P577
2012-02-01T00:00:00Z
2012-02-07T00:00:00Z